JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JB Accepts, published online ahead of print on 5 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JB.00925-07v1
189/24/8922    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eoh, H.
Right arrow Articles by Crick, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eoh, H.
Right arrow Articles by Crick, D. C.

 Previous Article  |  Next Article 

J. Bacteriol. doi:10.1128/JB.00925-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Characterization of the Mycobacterium tuberculosis 4–diphosphocytidyl–2–C–methyl–D–erythritol synthase: Potential for Drug Development

Hyungjin Eoh, Amanda C. Brown, Lori Buetow, William N. Hunter, Tanya Parish, Devinder Kaur, Patrick J. Brennan, and Dean C. Crick*

Mycobacterial Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, U.S.A., 80523; Centre for Infectious Disease, Institute for Cell and Molecular Science, Barts and the London, 4 Newark Street, London E1 2AT, UK, Division of Biological Chemistry and Molecular Microbiology, College of Life Sciences,University of Dundee, Dundee DD1 5EH, Scotland, UK

* To whom correspondence should be addressed. Email: Dean.Crick{at}colostate.edu.


   Abstract

Mycobacterium tuberculosis utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate and its isomer dimethylallyl diphosphate, precursors of all isoprenoid compounds. This pathway is of interest as a source of new drug targets as it is absent in humans and disruption of the responsible genes has shown a lethal phenotype in Escherichia coli. In the MEP pathway, 4–diphosphocytidyl–2–C–methyl–D–erythritol is formed from 2–C–methyl–D–erythritol 4–phosphate (MEP) and CTP, which is catalyzed by a 4–diphosphocytidyl–2–C–methyl–D–erythritol synthase (IspD). In the present work we have demonstrated that Rv3582c is essential in M. tuberculosis, Rv3582c has been cloned, expressed, and the encoded protein purified. The purified M. tuberculosis IspD was capable of catalyzing the formation of 4–diphosphocytidyl–2–C–methyl–D–erythritol in the presence of MEP and CTP. The enzyme was active over a broad pH range (pH 6.0 ~ 9.0), with peak activity at pH 8.0. The activity is absolutely dependent upon divalent cations with 20 mM Mg2+ being optimal, and replacement of CTP with other nucleotide 5'–triphosphates did not support activity. Under conditions tested, M. tuberculosis IspD has Km values of 58.5 µM for MEP and 53.2 µM for CTP. Calculated Kcat and Kcat/Km values were 0.72 min-1 and 12.3 mM-1min-1, for MEP and 1.0 min-1 and 18.8 mM-1min-1 for CTP, respectively.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.